Zeria Pharmaceutical Co Ltd
TSE:4559
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Zeria Pharmaceutical Co Ltd
Retained Earnings
Zeria Pharmaceutical Co Ltd
Retained Earnings Peer Comparison
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zeria Pharmaceutical Co Ltd
TSE:4559
|
Retained Earnings
ÂĄ59.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Retained Earnings
ÂĄ1.4T
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Retained Earnings
ÂĄ1.4T
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Retained Earnings
ÂĄ1.7T
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Retained Earnings
ÂĄ1.5T
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
13%
|
|
Astellas Pharma Inc
TSE:4503
|
Retained Earnings
ÂĄ809.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
See Also
What is Zeria Pharmaceutical Co Ltd's Retained Earnings?
Retained Earnings
59.3B
JPY
Based on the financial report for Mar 31, 2024, Zeria Pharmaceutical Co Ltd's Retained Earnings amounts to 59.3B JPY.
What is Zeria Pharmaceutical Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
5%
Over the last year, the Retained Earnings growth was 11%. The average annual Retained Earnings growth rates for Zeria Pharmaceutical Co Ltd have been 9% over the past three years , 6% over the past five years , and 5% over the past ten years .